Vaccination And Abortion

The Vaccine and Abortion Racket

It shocks many parents and even professionals alike when I mention that certain vaccines are cultured on aborted human foetal remains. The immediate response seems to be stunned silence followed by an incredulous ‘what?’ or just sheer disbelief. Even my health visitor exclaimed
‘Oh no, that can’t be right, you must have got that wrong!’ when I pointed out to her that the MMR vaccine she was promoting had aborted human baby in it.
It is a fact that to grow a virus or bacteria one must have an unclean medium on which to propagate the virus. To do this they would either use animal tissue, human blood products, genetically engineered yeast or aborted foetal tissue.

Why Medics Don’t Like Animal Tissue

Foetal tissue is the preferred choice for many vaccinologists as it avoids potential contamination with animal diseases and cross-transfer of animal DNA into humans.
According to Dr. Philip Brunel, Chief Medical Editor of ‘Infectious Diseases in Children’, March 2003, ‘About 40 years ago, cells from human embryos were grown in tissue culture…These strains, in contrast to the malignant cell lines that were existent at the time, retained their normal chromosome number and did not produce tumours. It was soon found, moreover, that they would support the growth of many viruses. Varicella virus and hepatitis A viruses were propagated in these cells, whereas it was difficult if not impossible to grow them in other types of cells. They provided an almost ideal substrate for the production of some of the vaccines we now use. Before the discovery of these cells, some vaccines were grown in avian eggs or cells derived from avian embryos. Other vaccines (eg, polio) were grown in kidney cells obtained by killing monkeys. In contrast to the human diploid cells, each time cells were required, a monkey had to be killed to obtain their kidney to produce cell cultures. This not only put a drain on the monkey population but also carried the risk of harbouring monkey viruses, eg, SV40, which is known to be oncogenic in some species. Also, some of the monkey’s bit handlers and infected them with herpes B virus, which was often fatal.’

Vaccines That Use Foetal Tissue

Currently, the following vaccines in the UK contain aborted foetal tissue: MMR II, MMR (Priorix), MR, Rabies (Imovax), Hepatitis A (Havarix and Avaxim brands). Old style single rubella vaccines contained foetal tissue, as well as some brands of single measles vaccines and the Medeva polio vaccine which was withdrawn for safety reasons.
In the USA, there is also an inject able polio vaccine by Connaught Labs which contains foetal tissue, as does the Varicella (Chickenpox) vaccine.

This practice began in the 1960’s when lung tissue was taken from an aborted female foetus, for use in the rubella vaccine, after she was terminated for mental health reasons by the mother. They also took tissue from a 14 week old male foetus, aborted for the same reason.

Newer cell lines from fetal tissue includes PER.C6 cell line from Merck, which used tissue from an 18 week old baby whose mother aborted it because she didn’t know who its father was. They also used tissue from a 21 week baby and this line is being used in flu and TB vaccines as well as experimental vaccines that researchers are still working on, including maleria and rabies vaccines, cancer and HIV vaccines. The tissue used was from both babies eyes.


It states in this PDF document on page 77, that:

‘The PER.C6 cell line was made by Ron Beut and Frits Fallaux in 1995 from embryonic retina cultures that were made from fetal tissue’ (part of the eye of the unborn baby). I have a copy of this document should anyone want me to email it to them.

And here is the glossy brochure advertising the PER.C6 cell line from aborted baby, including all the new vaccines in the pipeline that they are developing from it:

An Ethical Minefield

Miscarried babies cannot be used in the production of vaccines since most miscarriages are due to chromosomal abnormality and therefore renders the tissue too dangerous to use in case there is any transference of disease into the vaccinated person. Early embryonic cells can also not be used as they are not large enough to take a tissue sample from, therefore all unborn children used in vaccine production must be over the age of 12 weeks gestation and without any genetic abnormality.

Even for those who are pro a woman’s choice, may find this disrespectful use of human remains challenging.
It also raises the question of how we as a society value human life and whether in fact we have the right to place more importance on one baby’s life than another baby? Is it right to inject one baby with MMR to protect him from measles, using the body parts of a dead baby? Should one baby die to save another and what makes the child who receives MMR more important than the child who was used to make the drug? Would mothers even want it if they knew they were injecting their child with human remains?

It also means that the abortion industry is profiting from the sale of vaccines which contain their by-products. Whilst this author understands that there are heartbreaking circumstances that lead a woman to termination, and most people don’t make this decision lightly, an industry such as this should never be allowed to profit from the destruction of human life. They may argue that they still use the same cell lines, but foetal tissue is still widely used in bio-medical research even today, and new vaccine cell lines are being developed.

There are also many religious groups who are opposed to abortion who would find the use of foetal tissue in vaccines, unacceptable. At the Catholic Bishops conference of England and Wales 1994, religious leaders prepared a report on the subject which called vaccine use of aborted foetal tissue ‘a kind of evil which is widespread in biomedical research and which people rightly think they should combat when they can…the practice of medicine is being made parasitic on the evils of abortion and foetal experimentation.’
They add that ‘refusing vaccination is one way of seeking to turn medicine from a course which will increasingly subvert people’s confidence in it.’
According to Ethical and Religious Directives for Catholic Health Care Services (4th edition, 2001), ‘”Catholic health care institutions should not make use of human tissue obtained by direct abortions even for research and therapeutic purposes” (Directive 66).
Other religions such as Mormons, Jehovah’s Witnesses and fundamentalist Christians are all opposed to abortion and see it as anti-scriptural so getting any foetal containing vaccine would be against their philosophy.

Health Concerns With Foetal Tissue

There are also health risks associated with using human foetal tissue in vaccines, including the transference of diseases and genetic material which the foetus was carrying prior to its death. (1. Plotkin, SA, et al. Attenuation of RA 27-3 rubella virus in WI-38 human diploid cells. American Journal of Diseases of Children. Aug 1969. 118(2): 178-85.).

Vaccinating with human body parts can cause the recipient to produce antibodies to human tissue. Children produce antibodies to every component of the vaccine, and not simply the viruses. This can cause demylination of the nerves and auto-immune disorders.
Children who have been vaccinated with MMR and later suffered autism have been found to have antibodies to their own brain tissue, and this may be a consequence of using foetal tissue in MMR. ‘Susana C. Silva, Catarina Correia and Astrid M. Vicente at the Instituto Gulbenkian de Ciência, Oeiras, Portugal and colleagues studied the blood of a large sample of individuals – 171 patients, 191 parents and 54 healthy controls – and report that autistic patients are in fact characterised by presenting in their blood high levels of non-inherited antibodies against the body’s brain tissue.’ (Dr Catarina Amorim; Journal of Neuroimmunology; Instituto Gulbenkian de Ciência, Observatório da Ciência e do Ensino Superior, Portugal; July 23, 2004 –

This article is not intended to upset or offend anyone who may have gone through the pain of termination. My sympathies are with anyone who has experienced pregnancy loss of any form.

Vaccines, biotechnology and their connection with induced abortion

Source: Cuad Bioet. 2008 May-Aug;19(66):321-53.

Autism Link to Foetal Tissue in Vaccines


Impact of environmental factors on the prevalence of Autistic Disorder after 1979

‘Rising autistic disorder prevalance is directly related to vaccines manufactured utilizing human fetal cells.’

Full paper here:

Dr. Deisher testifies on the connection between vaccines and rising rates of autism

Epidemiologic and Molecular Relationship Between Vaccine Manufacture and Autism Spectrum Disorder Prevalence.

Source: ssues Law Med. 2015 Spring;30(1):47-70.

Anti-abortion mom wins right to not vaccinate her son

Open Letter from Dr Deisher to Legislators Regarding Contamination with Fetal DNA

I am writing regarding unrefuted scientific facts about fetal DNA contaminants in the Measles-Mumps-Rubella vaccine, which must be made known to lawmakers and the public.

Merck’s MMR II vaccine (as well as the chickenpox, Pentacel ,and all Hep-A containing vaccines) is manufactured using human fetal cell lines and are heavily contaminated with human fetal DNA from the production process. Levels in our children can reach up to 5 ng/ml after vaccination, depending on the age, weight and blood volume of the child. That level is known to activate Toll-like receptor 9 (TLR9), which can cause autoimmune attacks.

To illustrate the autoimmune capability of very small amounts of fetal DNA, consider this: labor is triggered by fetal DNA from the baby that builds up in the mother’s bloodstream, triggering a massive immune rejection of the baby. This is labor.

It works like this: fetal DNA fragments from a baby with about 300 base pairs in length are found in a pregnant mother’s serum. When they reach between 0.46– 5.08 ng/mL, they trigger labor via the TLR9 mechanism. The corresponding blood levels are 0.22 ng/ml and 3.12 ng/ml. The fetal DNA levels in a child after being injected with fetal-manufactured vaccines reach the same level that triggers autoimmune rejection of baby by mother.

Anyone who says that the fetal DNA contaminating our vaccines is harmless either does not know anything about immunity and Toll- like receptors or they are not telling the truth.

If fetal DNA can trigger labor (a naturally desired autoimmune reaction), then those same levels in vaccines can trigger autoimmunity in a child. Fragmented fetal DNA contained in vaccines is of similar size, ~215 base pairs.

This is direct biological evidence that fetal DNA contaminants in vaccines are not in low innocuous amounts. They are a very strong proinfla

mmatory trigger.

Administration of fragments of human fetal (primitive) non-self DNA to a child could generate an immune response that would also cross-react with the child’s own DNA, since the contaminating DNA could have sections of overlap very similar to the child’s own DNA.

Children with autistic disorder have antibodies against human DNA in their circulation that non- autistic children do not have. These antibodies may be involved in autoimmune attacks in autistic children.

Duke University demonstrated in a recently conducted study that significant improvements in behavior were observed when children with autism spectrum disorder were treated with their own banked autologous cord blood. This treatment clearly shows that most children with autism are not born with it since genetic diseases like Down syndrome or muscular fibrosis cannot be treated with autologous stem cells. Therefore, an environmental trigger, or triggers, introduced to the world around 1980 when autism first began to rise, must be identified and eliminated or reduced in the environment.

  • Strong change-point correlation exists between rising autism rates and the vaccine manufacturing switch from animal-derived cell lines for rubella vaccine to human aborted cell lines in the late 70s.
  • The earliest change point for Autistic Disorder (AD) birth year was identified for 1981 for California and U.S. data, preceded by a switch in the manufacturing process:
    • In January 1979, the FDA approved the manufacturing switch for the rubella virus from animal based (high passage virus, HPV-77, grown e.g. in duck embryo cells) to the human fetal cell line WI-38 using the RA27/3 virus strain. Both the newly approved monovalent rubella vaccine and a trivalent mumps, measles and rubella vaccine utilize the WI-38 fetal cell line for manufacturing of the rubella vaccine portion.Prior to 1980, autism spectrum disorder was a very rare, almost unknown disease. According to the figures of the CDC, the rate of autism in 2014 was 1 in 59 children, a very steep increase since just 2000, when it was 1 in 150. CDC: “The total costs per year for children with ASD in the United States were estimated to be between $11.5 billion – $60.9 billion (2011 US dollars).”

      Recently, duplications and de novo deletions have been recognized in up to 10% of simplex autism spectrum disorders, corroborating environmental triggers on the genetics of autism spectrum disorders.

      The rubella portion of the MMR vaccine contains human derived fetal DNA contaminants of about 175 ngs, more than 10x over the recommended WHO threshold of 10 ng per vaccine dose.

      No other drug on the market would receive FDA approval without thorough toxicity profiling (FDA follows international ICH guidelines) -> this was never conducted by the pharmaceutical industry for the DNA contamination in the MMR vaccine.

      Vaccines produced with human fetal cell lines contain cell debris and contaminating

      residual human DNA, which cannot be fully eliminated during the downstream purification process of the virus. Moreover, DNA is not only characterized by its sequence (ATCG), but also by its epigenetic modification (e.g. DNA methylation pattern etc.). This decoration is highly species specific, which is why non-human DNA will be eliminated through activation of TLR9 and consequent antibody production against the non-human DNA, while this is not necessarily the case with fetal human DNA.

      Injecting our children with human fetal DNA contaminants bears the risk of causing two well-established pathologies:

      1. Insertional mutagenesis: fetal human DNA incorporates into the child’s DNA causing mutations. Gene therapy using small fragment homologous recombination has demonstrated that as low as 1.9 ng/ml of DNA fragments results in insertion into the genome of stem cells in 100% of mice injected. The levels of human fetal DNA fragments in our children after vaccination with MMR, Varivax (chickenpox) or Hepatitis A containing vaccines reach levels beyond 1.9 ng/ml.
        2) Autoimmune disease: fetal human DNA triggers a child’s immune system to attack his/her own body.

      An additional concern: retrovirus contamination.

      Human endogenous retrovirus K (HERVK) is a contaminant in the measles/mumps/rubella vaccine.

      • HERVK can be reactivated in humans. It codes for a protein (integrase) specialized in integrating DNA into the human genome.
      • Several autoimmune diseases have been associated with HERVK activity.
      • It is also in the same family of retroviruses as the MMLV virus used in a gene therapy trial, in which inappropriate gene insertion (insertional mutagenesis) led to subsequent additional somatic mutations and cancer in 4 of 9 young boys.
      • It is therefore possible that the HERVK gene fragment present in the MMR vaccine is active, codes for the integrase or the envelope protein, and thus has the potential to induce gene insertion, fostering insertional mutagenesis and autoimmunity.

      The presence of both the high level contaminating fetal DNA as well as the HERVK contamination in the MMR vaccine is an unstudied risk with huge implications and dangers for individual and public health.

      Solution: Pressure manufacturers to switch back to animal cell line derived rubella vaccines as was successfully done in Japan:

      • Based on Takahashi strains of live attenuated rubella virus, produced on rabbit kidney cells. A single dose of this vaccine has been recently proven to retain immunity for at least 10 years when rubella was under regional control.
      • Split MMR vaccine into three individually offered options as done in Japan.

      The MMR vaccine manufacturing process needs to be changed to address and eliminate the above risks for the public.

      Thank you for your consideration. I will be happy to address any questions you may have concerning the above.

      Theresa A. Deisher, Ph.D.
      Lo et al. Am J Hum Genet. 1998 Apr;62(4):768-75
      Enninga et al. Front Immunol. 2015 Aug 26;6:424
      Deisher et al. Issues Law Med. 2015 Spring;30(1):47-70

      Mostafa et al. 2014, J Neuroimmunol , Vol. 272, pp. 94–98; Mostafa et al. 2015, J

      Neuroimmunol , Vol. 280, pp. 16–20
      Dawson et al. Stem Cells Transl Med. 2017 May;6(5):1332-1339

      Deisher et al. Issues Law Med, 2015 Vol. 30, pp. 25-46; Plotkin, SA. 2006,

      Clinical Infectious Diseases, Vol. 43, pp. S164–168;
      Sebat et al. 2007, Science., Vol. 316, pp. 445-449; Sanders et al. 2011, Neuron, Vol. 70, pp. 863-885


      STANDARDIZATION 941; Deisher et al. Issues Law Med. 2015 Spring;30(1):47-70

      Kramberger et al. Hum Vaccin Immunother. 2015;11(4):1010-21.

      McNeer, N A et al. “Systemic delivery of triplex-forming PNA and donor DNA by nanoparticles mediates site-specific genome editing of human hematopoietic cells in vivo.” Gene therapy vol. 20,6 (2012): 658-69. doi:10.1038/gt.2012.82

      Victoria et al. J Virol. 2010, Vol. 84, pp. 6033-6040

      Lee et al. PLoS Pathog. 2007 3(1):e10; Dewannieux et al. Biologicals, Vol. 38, pp. 366-70

      Taietal.9,Nov2008, Mult Scler, Vol. 14, pp. 1175-80; Dickerson et al. 2008, Schizophr Res. 2008 Sep;104(1-3):121-6, Vol. 104, pp. 121-6

      Hacein-Bey-Abina et al. J Clin Invest. 2008 Sep;118(9):3132-42

      Jpn J Infect Dis. 2016 May 20;69(3):221-3.

Source: Warning: Children Could Be Infected With Heavily Contaminated Human Fetal DNA In Vaccines, Modern Ghana, 17th May 2019.